The occurrence of conjunctival scarring finally leads to the obstruction of the fistula tract created by the filtering surgery. Vascular endothelial growth factor is thought to be a key role in the formation of conjunctival scar, which play a pivotal role in the wound-healing process. So it seems that the recombinant human anti-VEGF antibody could inhibit angiogenesis, and reduce the conjunctival vascular formation in the wound-healing process after glaucoma filtering surgery.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
30
0.05ml, 1.25mg
Tongren hospital
Beijing, Beijing Municipality, China
bleb vascular change
Time frame: one day, one week, one month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.